Guardant Health
GH
#3559
Rank
C$4.18 B
Marketcap
$34.03
Share price
-1.18%
Change (1 day)
-7.87%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yields for this company